Peptides are short chains of amino acids that serve many functions in the body. In clinical discussions, peptide molecules may be referenced in connection with prescription products, compounded formulations, and research.
It is important to understand that “peptide therapy” is not a single FDA-approved category. Some peptide molecules are included in FDA-approved prescription products for specific uses, while many others have not been approved by the U.S. Food and Drug Administration.
Only a limited number of peptide molecules are part of FDA-approved prescription products. Many others, including certain custom-compounded formulations, have not received FDA approval.
This distinction is important because FDA approval applies to a specific product for a specific intended use. It does not apply broadly to all peptide molecules or to all compounded products.
FDA approval means a specific product has undergone formal review by the agency. However, not every peptide molecule being discussed has gone through that same process.
Compounded products are different from FDA-approved products. They are not reviewed by the FDA in the same manner for safety, effectiveness, or quality before being dispensed.
Because of this, patients should ask direct questions about the regulatory status of any peptide molecule being considered.
When discussing peptide molecules, product quality and sourcing are important considerations. Some peptide formulations may be prepared by licensed compounding pharmacies or other regulated facilities. However, this does not mean that a specific compounded peptide product is FDA-approved.
Patients should feel comfortable asking:
Clear information helps patients make informed decisions.
It is important to speak with a qualified licensed medical professional. A consultation can help you better understand:
These conversations should be based on transparency, current information, and careful review of the specific product in question.
In recent years, the FDA has increased scrutiny around certain compounded peptide molecules. As a result, availability may change over time based on regulatory updates, compounding rules, and pharmacy practices.
As with any healthcare decision, it is wise to do your research and choose a provider who is transparent about the FDA status of any product they discuss.
Dr. Judi Goldstone is a board-certified physician. After graduating cum laude from the University of California at Los Angeles, she earned her medical degree from Mount Sinai School of Medicine in New York, where she graduated at the top of her class. Dr. Goldstone is certified by the American Board of Internal Medicine and is a member of the American Society of Bariatric Physicians. She also joined the American Academy of Anti-Aging and Regenerative Medicine in 2005.
If you have questions about peptides, compounded formulations, or the FDA status of specific products, our team can help you better understand the available information.
Call our office at (424) 374-2800 or contact us online today. We also offer convenient telehealth services and virtual consultations.
